Prof. Paul Stott, CEO of Seda Pharmaceutical Development Services is to chair the Pharmaceutical Development panel session at the virtual Bionow Oncology conference on Thursday November 5^th. Speakers include Mike Frodsham (Quay Pharma), Claire Patterson (Seda),  Alyn McNaughton (Lonza Group) and Lyn Daintree (Crystec Pharma). Presentations focus on the role and opportunities for drug delivery in the increasingly complex arena of cancer therapeutics.

More information about Seda’s oral drug delivery expertise can be found on our website.